---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-071452"
form_type: "8-K"
ticker: "CALC"
cik: "0001534133"
company_name: "CalciMedica, Inc."
filed_at: "2023-03-15T23:59:59+00:00"
generated_at: "2026-06-18T02:00:11.048698+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Graybug stockholders approve merger with CalciMedica; 14-to-1 reverse split effective Mar 17

## Summary
- All five proposals approved: share issuance (13.2M for), charter amendment, equity plan, ESPP, and adjournment.
- Reverse stock split ratio set at 14-to-1, effective after market close March 17, 2023.
- Outstanding shares will reduce from ~22M to ~1.57M; no fractional shares—cash in lieu.
- Common stock to trade split-adjusted on Nasdaq under new CUSIP 38942Q 202 starting March 20.
- Merger with CalciMedica remains subject to customary closing conditions; no closing date announced.

## SEC filing metadata
- accession: 0001193125-23-071452
- form_type: 8-K
- ticker: CALC
- cik: 0001534133
- company_name: CalciMedica, Inc.
- filed_at: 2023-03-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534133/000119312523071452/0001193125-23-071452-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534133/000119312523071452/d481564d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-071452
- JSON: https://secwatch.observer/filing/0001193125-23-071452.json
- Plain text: https://secwatch.observer/filing/0001193125-23-071452.txt

## Key facts
- Shareholder Votes
  CalciMedica, Inc. shareholders approved To approve the CalciMedica 2023 Equity Incentive Plan. at the 2023-03-15 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-03-15
  source text: PROPOSAL 3 "The CalciMedica 2023 Equity Incentive Plan Proposal": To approve the CalciMedica 2023 Equity Incentive Plan. For Against Abstain 12,085,467 1,957,455 287,613
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534133/000119312523071452/0001193125-23-071452-index.htm
- Shareholder Votes
  CalciMedica, Inc. shareholders approved To approve the issuance of Graybug common stock in the Merger and the resulting change of control under the Nasdaq Rules (Share Issuance Proposal). at the 2023-03-15 meeting.
  - Proposal: merger approval
  - Outcome: passed
  - Meeting: 2023-03-15
  source text: PROPOSAL 1 "The Share Issuance Proposal": To approve the issuance of Graybug common stock in the Merger and the resulting change of control under the Nasdaq Rules. For Against Abstain 13,155,174 1,160,128 15,233
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534133/000119312523071452/0001193125-23-071452-index.htm
- Shareholder Votes
  CalciMedica, Inc. shareholders approved To approve the Amended and Restated Certificate of Incorporation. at the 2023-03-15 meeting.
  - Proposal: charter amendment
  - Outcome: passed
  - Meeting: 2023-03-15
  source text: PROPOSAL 2 "The Amended and Restated Certificate of Incorporation Proposal": To approve the Amended and Restated Certificate of Incorporation. For Against Abstain 13,142,209 1,170,391 17,935
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534133/000119312523071452/0001193125-23-071452-index.htm
- Shareholder Votes
  CalciMedica, Inc. shareholders approved To approve the possible adjournment of the Special Meeting. at the 2023-03-15 meeting.
  - Outcome: passed
  - Meeting: 2023-03-15
  source text: PROPOSAL 5 "Possible Adjournment of the Special Meeting Proposal": To approve the possible adjournment of the Special Meeting. For Against Abstain 12,820,365 1,424,995 85,175
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534133/000119312523071452/0001193125-23-071452-index.htm
- Shareholder Votes
  CalciMedica, Inc. shareholders approved To approve the CalciMedica 2023 Employee Stock Purchase Plan. at the 2023-03-15 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-03-15
  source text: PROPOSAL 4 "The CalciMedica 2023 Employee Stock Purchase Plan Proposal": To approve the CalciMedica 2023 Employee Stock Purchase Plan. For Against Abstain 13,118,277 943,669 268,589
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534133/000119312523071452/0001193125-23-071452-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.